Association of Serum 17β-estradiol Concentration, Hormone Therapy, and Alveolar Crest Height in Postmenopausal Women

Overview

Journal J Periodontol

Date 2015 Jan 17

PMID 25594424

Citations 6

Authors

Youjin Wang

Michael J LaMonte

Kathleen M Hovey

Xiaodan Mai

Mine Tezal

Amy E Millen

Heather M Ochs-Balcom

Robert J Genco

Vanessa M Barnabei

Jean Wactawski-Wende

Affiliations

Soon will be listed here.

Abstract

Background: Declines in endogenous estrogen levels after menopause can lead to systemic bone loss, including loss of oral bone and alveolar crest height (ACH). However, few studies have assessed both serum 17β-estradiol (E2) and exogenous hormone therapy (HT) use in relation to oral bone loss.

Methods: This study examines the associations among serum E2, HT use, and ACH in 613 postmenopausal women from the Buffalo OsteoPerio study. Baseline ACH levels and 5-year ACH were assessed for groups according to E2 level (undetectable, >5.00 to ≤18.00, >18.00 to ≤46.07, and >46.07 pg/mL) and among HT use (never, ever) using analysis of variance and analysis of covariance. Logistic regression was used to analyze the association of ACH loss with serum E2 and HT use.

Results: In cross-sectional analyses, no association was found of serum E2 with whole-mouth mean or worst-site ACH. However, history of HT use was associated with ACH. Women who had never used HT had more ACH loss assessed as a whole-mouth mean ACH (P = 0.01) and as worst-site ACH loss (P = 0.03). In logistic regression analyses of baseline ACH loss severity, HT never-users had two-fold higher odds of being in the severe ACH loss category compared to ever-users (odds ratio, 2.00; 95% confidence interval, 1.11 to 3.62). No association was observed of 5-year change in ACH with baseline serum E2 or HT use.

Conclusion: Although this study did not detect an association with current serum E2 level and ACH, HT use was found to be associated with less ACH loss in postmenopausal women.

Citing Articles

Associations between the incidence of Fuchs' endothelial corneal dystrophy and menopausal hormone therapy use and exposure to endogenous estrogen.

Millen A, Nie J, Yue Y, Andrews C, Wactawski-Wende J, Wallace R Maturitas. 2024; 191():108132.

PMID: 39522475 PMC: 11733839. DOI: 10.1016/j.maturitas.2024.108132.

The association of reproductive health factors with periodontitis in 45-80 years old US women from NHANES 2009-2014.

Liu Y, Yin T, He M, Fang C, Peng S Clin Oral Investig. 2024; 28(11):623.

PMID: 39495330 DOI: 10.1007/s00784-024-06018-1.

Serum Follicle-Stimulating Hormone and 5-Year Change in Adiposity in Healthy Postmenopausal Women.

Mattick L, Bea J, Singh L, Hovey K, Banack H, Wactawski-Wende J J Clin Endocrinol Metab. 2022; 107(8):e3455-e3462.

PMID: 35435955 PMC: 9282244. DOI: 10.1210/clinem/dgac238.

Succinate-Based Dietary Supplement for Menopausal Symptoms: A Pooled Analysis of Two Identical Randomized, Double-Blind, Placebo-Controlled Clinical Trials.

Radzinsky V, Uspenskaya Y, Shulman L, Kuznetsova I Obstet Gynecol Int. 2019; 2019:1572196.

PMID: 31781230 PMC: 6875258. DOI: 10.1155/2019/1572196.

Estrogen signaling impacts temporomandibular joint and periodontal disease pathology.

Robinson J, Johnson P, Kister K, Yin M, Chen J, Wadhwa S Odontology. 2019; 108(2):153-165.

PMID: 31270648 PMC: 7192637. DOI: 10.1007/s10266-019-00439-1.

References

Genco R, Grossi S . Is estrogen deficiency a risk factor for periodontal disease?. Compend Contin Educ Dent Suppl. 2002; (22):S23-9. View

Graves D, Li J, Cochran D . Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res. 2010; 90(2):143-53. PMC: 3144100. DOI: 10.1177/0022034510385236. View

Langer R, White E, Lewis C, Kotchen J, Hendrix S, Trevisan M . The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003; 13(9 Suppl):S107-21. DOI: 10.1016/s1047-2797(03)00047-4. View

Sowers M, Zheng H, McConnell D, Nan B, Harlow S, Randolph Jr J . Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab. 2008; 93(10):3847-52. PMC: 2579642. DOI: 10.1210/jc.2008-1056. View

Tezal M, Scannapieco F, Wactawski-Wende J, Hyland A, Marshall J, Rigual N . Local inflammation and human papillomavirus status of head and neck cancers. Arch Otolaryngol Head Neck Surg. 2012; 138(7):669-75. PMC: 4477511. DOI: 10.1001/archoto.2012.873. View

Taguchi A, Sanada M, Suei Y, Ohtsuka M, Nakamoto T, Lee K . Effect of estrogen use on tooth retention, oral bone height, and oral bone porosity in Japanese postmenopausal women. Menopause. 2004; 11(5):556-62. DOI: 10.1097/01.gme.0000113845.74462.bf. View

Karim R, Mack W, Hodis H, Roy S, Stanczyk F . Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J Clin Endocrinol Metab. 2009; 94(11):4136-43. PMC: 2775642. DOI: 10.1210/jc.2009-0643. View

Papapanou P, Wennstrom J . Radiographic and clinical assessments of destructive periodontal disease. J Clin Periodontol. 1989; 16(9):609-12. DOI: 10.1111/j.1600-051x.1989.tb02146.x. View

Walsh T, Fosam E . The relationship of bone loss observed on panoramic radiographs with clinical periodontal screening. J Clin Periodontol. 1997; 24(3):153-7. DOI: 10.1111/j.1600-051x.1997.tb00484.x. View

10.

Hausmann E, Allen K, Dunford R, Christersson L . A reliable computerized method to determine the level of the radiographic alveolar crest. J Periodontal Res. 1989; 24(6):368-9. DOI: 10.1111/j.1600-0765.1989.tb00884.x. View

11.

Norderyd O, Grossi S, Machtei E, Zambon J, Hausmann E, Dunford R . Periodontal status of women taking postmenopausal estrogen supplementation. J Periodontol. 1993; 64(10):957-62. DOI: 10.1902/jop.1993.64.10.957. View

12.

Royston P, Altman D, Sauerbrei W . Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2005; 25(1):127-41. DOI: 10.1002/sim.2331. View

13.

LaMonte M, Hovey K, Genco R, Millen A, Trevisan M, Wactawski-Wende J . Five-year changes in periodontal disease measures among postmenopausal females: the Buffalo OsteoPerio study. J Periodontol. 2012; 84(5):572-84. DOI: 10.1902/jop.2012.120137. View

14.

Payne J, Reinhardt R, Nummikoski P, Patil K . Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int. 1999; 10(1):34-40. DOI: 10.1007/s001980050191. View

15.

Benn D . A review of the reliability of radiographic measurements in estimating alveolar bone changes. J Clin Periodontol. 1990; 17(1):14-21. DOI: 10.1111/j.1600-051x.1990.tb01041.x. View

16.

Payne J, Zachs N, Reinhardt R, Nummikoski P, Patil K . The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol. 1997; 68(1):24-31. DOI: 10.1902/jop.1997.68.1.24. View

17.

Hausmann E, Allen K, Carpio L, Christersson L, Clerehugh V . Computerized methodology for detection of alveolar crestal bone loss from serial intraoral radiographs. J Periodontol. 1992; 63(8):657-62. DOI: 10.1902/jop.1992.63.8.657. View

18.

Armitage G . Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004; 34:9-21. DOI: 10.1046/j.0906-6713.2002.003421.x. View

19.

Rapuri P, Gallagher J, Haynatzki G . Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women. J Clin Endocrinol Metab. 2004; 89(10):4954-62. DOI: 10.1210/jc.2004-0434. View

20.

Patterson R, Kristal A, Tinker L, Carter R, Bolton M, Agurs-Collins T . Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999; 9(3):178-87. DOI: 10.1016/s1047-2797(98)00055-6. View